Nektar’s 40% drop yesterday was an extreme over-reaction: What I’m doing now
It’s never good to turn in disappointing results in a drug trial–as Nektar Therapeutics (NKTR) did over the weekend–but to whack 40% off the stock price on this news is an extreme over-reaction. To justify a 40% drop you have to assume 1) that the...
Apple’s Worldwide Developers Conference focuses on catching up and differentiation
The keynote that opened Apple’s (AAPL) Worldwide Developers Conference (June 4 through 8) walked a tough balancing act between admitting that Apple needs to catch up with competitors in some areas (Poor Siri) and introducing stuff that will differentiate Apple from...
FDA delivers less than half a loaf to INCY and LLY in approving Olumiant
Today the U.S. Food & Drug Administration did finally approve Baricitinib, now known as Olumiant, for the treatment of moderately-to-severely active rheumatoid arthritis. But the approval carries more restrictions than expected. The FDA approved only the 2...
Canadian government buys Trans Mountain Pipeline and removes huge albatross from neck of Kinder Morgan
Yesterday the Canadian government announced that it will buy the Trans Mountain Pipeline from Kinder Morgan Canada for CAD$ 4.5 billion. Kinder Morgan (KMI), a member of my Dividend Portfolio, owns a 70% stake in Kinder Morgan Canada. The sale, which certainly...
Book keeping changes: Statoil (STO) changes its name and ticker to Equinor (EQNR)
A change in the name and ticker of portfolio holding Statoil (STO). The explanation offered by the company is that it wanted to remove “oil” from its name to better reflect the company’s increasing emphasis on other forms of energy including wind...
Adding shares of Valero Energy to my Jubak Picks Portfolio
Last night on my JubakAM.com and JugglingWithKnives.com subscription sites I laid out the case argued by Morgan Stanley for believing that distillate prices are heading higher in the face of a tight supplies for these refinery products. One of the refiners Morgan...
Stock or options, Nektar needs some understanding and patience now
It hasn’t exactly been a stellar couple of months for shares and options on Nektar Therapeutics (NKTR). The stock, which I hold in my Jubak Picks portfolio, is down 23.1% since it hit a high of $108.44 on March 8. The August 17, 2018 call options with a strike...
Putting gold back into the 50 Stocks Portfolio with Randgold Resources
My criteria for adding a gold stock to my long-term 50 Stocks portfolio have been reasonably consistent over the years: I’ve looked for a gold miner that was growing gold production and reducing production costs. Up until my latest revision of this portfolio in...
Amazon targets digital display ad market with new tool
OK, so even remembering that announcing a new technology product isn’t the same as actually putting a working product into the market (as Microsoft (MSFT) and Intel (INTC) have proved over the years), but this announcement from Amazon (AMZN) is still a very big...
Nvidia crushes earnings; stock falls after hours
Okay, if you’re a trader I sort of understand selling Nvidia (NVDA) after today’s earnings report: Sell on the news; How can it get better? How long can the company keep it up? After all, the stock closed today just pennies below it’s all time high....
No surprise: Oil moves higher on day after U.S. pulls out of Iran nuclear deal
Some days you need to search for an explanation for a market move. Other days the explanation hits you over the head. Today crude oil is up, in a strong but orderly move. Two catalysts. First, yesterday President Donald Trump announced that the U.S. would pull out of...
SolarEdge Technologies beats on earnings and revenue; raises guidance
SolarEdge Technologies (SEDG), a member of my Jubak Picks portfolio, reported first quarter earnings today after the New York markets closed of 87 cents a share, 7 cents a share better than Wall Street projections. Revenue climbed 82.4% year over year (and 10.8% from...
Ignore the short-term oil volatility and continue to hold Pioneer Natural Resources for the long-term story
So much near-term noise. Since Pioneer Natural Resources (PXD) reported earnings on May 2–the company beat Wall Street estimates on earnings by 16 cents a share and reported revenue in-line with projections and up 56.5% year over year–there’s been...
Apple beats on earnings; iPhone sales of 52.2 million slightly below consensus of 52.3 million units
It wasn’t a big beat and iPhone sales weren’t wildly above consensus, but such was the fear and skepticism surrounding Apple (AAPL) that shares rose 3.61% in trading after the earnings announcement. The company reported earnings of $2.73 a share, five...
Merck moves lower in spite of earnings beat
This morning before the New York markets opened Merck (MRK) reported earnings of $1.05 a share, ahead of the $1.00 a share forecast by Wall Street analysts. Earnings were up 19.3% from the first quarter of 2017. Revenue grew 6% to $10 billion. That narrowly missed the...
McDonald’s jumps on earnings beat
McDonald’s reported a solid earnings beat of 12 cents a share ($1.79 vs expectations for $1.67) before the market opened today, April 30. Revenue fell 9.5% year over year to $5.14 billion but that was still ahead of the $4.97 billion Wall Street consensus for...
Positive catalysts are intact for Nektar Therapeutics
Shares of biotech rocket Nektar Therapeutics (NKTR) are down 23.25% since they traded at $106.91 on March 21, 2018. I can’t find evidence that the positive catalysts that led me to recommend the stock for my Jubak Picks portfolio and the options for my...
Israel’s Prime Minister announces major statement Monday night on Iranian nuclear program
Israeli Prime Minister Benjamin Netanyahu has announced that he will make a statement at 8 p.m. Tel Aviv time tonight on a “significant development” regarding the Iranian nuclear pact. (As best as I can do the conversions, 8 p.m. in Tel Aviv is 1 p.m. in New York.)...
Adding Merck to my Dividend Portfolio
News out of the imuno-oncology sector of the biotech world has hit stocks in my portfolios such as Incyte (INCY) and Nektar Therapeutics (NKTR) hard. But, I’d argue that it has left Keytruda and its owner Merck (MRK) in a measurably stronger position in the...
Time to add China Southern Airlines to my 50 Stocks Portfolio
I’ve been looking to add shares of China Southern Airlines (ZNH) to my long-term 50 Stocks ever since I saw the newest list of the world’s 20 busiest airports from the Airports Council International on April 6. Atlanta’s Hartsfield-Jackson...
Did Intel and Amazon finally break the sell on earnings beat pattern today?
Amazon (AMZN), Intel (INTC), and Microsoft (MSFT) all reported earnings after the close today. All three beat earnings estimates–but this market hasn’t been very generous in rewarding earnings surprises (after Netflix (NFLX)) that is. The key tests here...
Statoil drops after 33% jump in profit falls short of Wall Street hopes
There’s no pleasing the market these days. Shares of Statoil (STO) fell 1.54% to $24.96 today after the company reported first quarter earnings of $4.4 billion, its highest quarterly profit in three years and 33% higher than in the first quarter of 2017. But the...
GOOG gets hit by market profit margin fears even after good earnings
Some times in the financial markets, the numbers aren’t as important as the narrative. I think that was the case with Alphabet (GOOG), Tuesday, April 24. Monday after the market close Alphabet reported first quarter earnings of $9.93. That was a healthy 64 cents...
Kinder Morgan raises dividend by 60%
he earnings results for Kinder Morgan’s (KMI) first quarter were in line; it’s 60% increase in the annual dividend was more aggressive than expected. Adjusted EBITDA (earnings before interest payments, taxes, and depreciation) was $1.90 billion for the...
Oil continues to move higher on Middle East fears
Oil futures in New York settled at their highest since December 2014. U.S. benchmark West Texas Intermediate climbed 0.35% to close at $68.88 a barrel. International benchmark Brent crude rose 0.88% to $74.71 a barrel. The gains were unusual in that the U.S. dollar...
Dividend Portfolio member Independent Bank beats on earnings today
Independent Bank (IBCP) reported first quarter earnings of 42 cents a share today. That’s up from 28 cents a share in the first quarter of 2017. Special items added 4 cents a share to earnings. The reduction in the bank’s tax rate thanks to the Tax Cuts...
Bank of America struggles after earnings beat, sees some traction today
On Monday Bank of America (BAC) reported first quarter earnings of 62 cents a share, 3 cents a share above Wall Street estimates. Earnings were up 51% year over year on a 4% increase of revenue to $23.1 billion. That was ahead of the consensus at $23.04 billion. Wall...
Raising target price on Danaher after earnings beat today
Danaher (DHR) reported fourth quarter earnings of 80 cents a share before the market opened today, April 19. That was 3 cents a share ahead of Wall Street projections. Revenue climbed 10.9% year over year to $5.09 billion. The Wall Street consensus called for $4.97...
Oil prices up again on inventories, Middle East fears, OPEC price goals
West Texas Intermediate crude climbed 3.16% today to $68.80 a barrel. Futures for May delivery moved over $68 a barrel for the first time in three years. Yesterday the American Petroleum Institute reported a 1.05 million barrel draw down in U.S. inventories. Today the...Jim’s Daily Email Alerts:
Every post from Jubak Picks straight to your mailbox. And they're free!